List Title | APhA DrugInfoLine

Neurology

SORT BY: Most Recent Most Viewed

March 27, 2017

New guidance on diabetic neuropathy

READ

PREVIEW
A new position statement by the American Diabetes Association (ADA) focuses on prevention, screening, and management of several diabetic neuropathies, including distal symmetric polyneuropathy (...
March 21, 2017

Effective contraception methods not used by one-third of women with epilepsy

READ

PREVIEW
Approximately 30% of women with epilepsy (WWE) who were of reproductive age and receiving various antiepileptic drugs (AEDs) were not using highly effective methods of contraception, according to...
January 24, 2017

Analgesics and opioids for migraines result in more medication overuse headaches

READ

PREVIEW
Use of analgesics (e.g., NSAIDs) and opioids for management of acute migraines were associated with a higher risk of medication overuse headaches compared with triptans and ergots, according to...
January 3, 2017

Anticholinergic medications linked to brain atrophy, cognitive impairment

READ

PREVIEW
Use of anticholinergic medications in older adults was associated with brain atrophy and dysfunction as well as lower mean scores on tests of short-term memory and executive function, according to...
September 20, 2016

Debunking the myths of serotonin syndrome

READ

PREVIEW
Results of a meta-analysis of case reports of serotonin syndrome indicated that this syndrome may not be captured by current criteria systems, may develop quickly or slowly, and may or may not be...

Pages

Medication Monitor

RSS Follow Medication Monitor on Twitter Follow APhA Druginfoline on Twitter

2215 Constitution Avenue NW, Washington, DC 20037 Telephone 202-628-4410 Fax 202-783-2351

© 2013 American Pharmacists Association All Rights Reserved.

About the American
Pharmacists Association

The American Pharmacists Association (APhA) is the organization whose members are recognized in society as essential in all patient care settings for optimal medication use that improves health, wellness and quality of life. Through information, education and advocacy, APhA empowers its members to improve medication use and advance patient care.

About APhA DrugInfoLine

APhA DrugInfoLine (ISSN 2162-3015) is a weekly publication of, and is owned and copyrighted by the American Pharmacists Association, the national professional society of pharmacists. Materials in APhA DrugInfoLine do not neccessarily represent the policy, recommendations, or endorsement of APhA. The publisher, authors, editors, reviewers, and contributors have taken care to ensure that the information contained in APhA DrugInfoLine is accurate and current; however, they shall have no ability to any person or entity with regard to claims, losses, or damage caused or alleged to be caused, directly or indirectly by use of any information contained in the publication. All decisions about drug therapy must be based on independent judgement of the clinician.